Skip to main content
CREIGHTONS PLC logo

CREIGHTONS PLC — Investor Relations & Filings

Ticker · CRL ISIN · GB0002341666 LEI · 213800WROWAJUBGSAJ57 IL Manufacturing
Open in API
Filings indexed 332 across all filing types
Latest filing 2021-02-25 Director's Dealing
Country GB United Kingdom
Listing IL CRL

About CREIGHTONS PLC

http://www.creightonsplc.com/

Creightons PLC is a company that designs, develops, manufactures, and distributes a wide range of beauty and personal care products. Its portfolio encompasses skincare, haircare, wellbeing products, toiletries, and fragrances. The company operates through multiple business models, including developing its own brands, providing private label manufacturing for major retailers, and offering contract manufacturing services for other brand partners. Creightons manages the entire product lifecycle, from concept to distribution, and maintains full-service supply partnerships with key brands and retailers in both domestic and international markets.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal announcement identified by the 'RNS Number' and references to 'Market Abuse Regulation' and the 'London Stock Exchange'. The content explicitly details a transaction involving shares by a director ('Paul Forster') and his wife, including the nature of the transaction ('Share disposal') and the resulting holding percentage. This directly matches the definition of Director's Dealing (insider trades). The corresponding code is DIRS.
2021-02-25 English
Further Statement regarding Innovaderma
M&A Activity Classification · 100% confidence The document is identified by the RNS Number (2579Q) and explicitly states it is being released via RNS, the news service of the London Stock Exchange. The content discusses a 'Further Statement regarding Innovaderma plc' concerning the withdrawal of a potential offer and references the 'UK City Code on Takeovers and Mergers (the "Code")' and Rule 2.8. This subject matter directly relates to merger/takeover activity. Therefore, the most specific classification is M&A Activity (TAR). Although it is an RNS announcement, the core subject matter is M&A, making TAR more precise than the general RNS fallback.
2021-02-24 English
Form 8.3 - Creightons
Director's Dealing Classification · 95% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is used for 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' concerning an offeror/offeree (Creightons PLC). This type of disclosure relates to insider/director dealings or major shareholder changes during a takeover scenario. The closest matching category among the provided definitions is 'Director's Dealing' (DIRS), as it concerns personal share transactions by individuals connected to the company, although this specific form is mandated by the Takeover Code. Since the document details the interests and potential dealings of an individual (Brian Geary) in the securities of an offeree company during a potential offer, DIRS is the most appropriate fit, as it covers executive/insider transactions. It is not a general regulatory filing (RNS) because it is a highly specific disclosure type (Form 8.3).
2021-02-12 English
Rule 2.9 Announcement
Regulatory Filings Classification · 98% confidence The document starts with 'RNS Number' and contains boilerplate language typical of regulatory news service announcements, specifically mentioning 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' The content itself is a confirmation of the total number of ordinary shares in issue (64,757,243) made in accordance with Rule 2.9 of The City Code on Takeovers and Mergers. This is a routine regulatory disclosure, not a comprehensive report (like 10-K or IR) or a specific announcement like a dividend (DIV) or management change (MANG). Since it is a general regulatory announcement distributed via RNS and doesn't fit a more specific category like DIRS, SHA, or POS, the most appropriate classification is the general Regulatory Filings category (RNS). The document length is short, confirming it is an announcement, not the full report.
2021-02-04 English
Form 8 (OPD) CREIGHTONS
Director's Dealing Classification · 95% confidence The document is titled "FORM 8 (OPD) PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER" and explicitly references "Rules 8.1 and 8.2 of the Takeover Code (the 'Code')". This form is used to disclose interests and short positions related to a takeover offer. This type of disclosure, which relates to insider/director dealings or share ownership changes in the context of a specific corporate action (takeover), is not explicitly covered by the primary definitions like 10-K, ER, or IR. However, it is a specific regulatory filing related to insider activity/ownership changes during a takeover scenario. Since it details shareholdings and options of directors/persons acting in concert, it shares characteristics with Director's Dealing (DIRS) or Major Shareholding Notification (MRQ), but the context is strictly a Takeover Code disclosure (Form 8). Given the options, this specific regulatory disclosure about ownership during an offer is best categorized as a specialized regulatory filing. Since it is a formal disclosure mandated by the Takeover Panel, and it details director holdings, it is most closely related to insider/director activity reporting, but the most appropriate general category for specific, non-standard regulatory disclosures that aren't financial reports or standard governance documents is often RNS (Regulatory Filings) or, if focusing on the content, DIRS. Since this is a mandatory disclosure under the Takeover Code (Form 8), and not a standard Director's Dealing report (Form 4/Form 8 in the US context, or similar UK forms), and it is not a general announcement, I will classify it based on its nature as a specific regulatory filing mandated by the Takeover Panel, which often falls under the general regulatory announcement category if a more specific one isn't available. However, the content heavily involves director shareholdings and options, which aligns with DIRS. Given the strict definitions, and the fact that this is a mandatory disclosure related to a takeover offer, it is a highly specific regulatory filing. Since it details director holdings, DIRS is a strong candidate, but DIRS usually refers to routine insider trading reports. Given the context of the Takeover Code, and the fact that it is a formal disclosure published via RNS, RNS is the safest fallback for specific, non-standard regulatory disclosures. Let's re-evaluate: Director's Dealing (DIRS) covers personal share transactions by directors. This document details director shareholdings and options in the context of an offer. This is a disclosure of director interests. I will classify it as DIRS due to the focus on director holdings, even though the form is specific to the Takeover Code. If DIRS is too narrow, RNS is the fallback. Given the detailed breakdown of director holdings, DIRS is the most content-specific fit among the choices provided for insider/director activity reporting. I will use DIRS, as it reports on the interests of directors/persons acting in concert.
2021-02-04 English
Statement regarding Innovaderma plc
M&A Activity Classification · 100% confidence The document is an RNS announcement dated February 2, 2021, detailing a preliminary approach made by Creightons plc to Innovaderma plc regarding a possible offer (takeover). It explicitly references the 'City Code on Takeovers and Mergers (the "Code")' and discusses potential offer ratios and disclosure rules (Rule 2.4, Rule 2.7, Rule 2.5, Rule 2.6, Rule 8.3). This content directly relates to merger proposals or takeover bids. Therefore, the appropriate classification is M&A Activity (TAR). Although it is an RNS announcement, the specific subject matter (Takeover approach) is more precise than the general 'Regulatory Filings' (RNS) fallback.
2021-02-02 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.